AIXC
AIxCrypto Holdings, Inc. · Healthcare
AIxCrypto Holdings, Inc. · Healthcare
AIxCrypto Holdings, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase I clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. The company was formerly known as Qualigen Therapeutics, Inc. and changed its name to AIxCrypto Holdings, Inc. in November 2025. The company was founded in 1996 and is based in Carlsbad, California.
Healthcare
Medical - Pharmaceuticals
4
2015-06-23
0.38

LOS ANGELES, April 6, 2026 /PRNewswire/ -- AIxCrypto Holdings, Inc. (NASDAQ: AIXC) ("AIxC" or the "Company"), a technology company focused on infrastructure for the emerging Embodied AI (EAI) and on-chain asset ecosystem, today shared a weekly business update from Co-CEO Jerry Wang highlighting continued progress in the Company's AI Agent strategy, including ongoing development across key modules and the start of initial internal enterprise testing aimed at supporting workflow optimization and practical use case refinement. Advancing AI Agent-Related Development Efforts This week, AIxC continued to advance its broader AI Agent strategy, with development work across key modules and supporting infrastructure remaining on track.

LOS ANGELES, March 30, 2026 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ: AIXC) ("AIxC" or the "Company"), a technology company focused on infrastructure for the emerging Embodied AI ("EAI") ecosystem, today highlighted key takeaways from its recently released full year 2025 results and provided an update on the Company's continued strategic development. Annual Report Highlights Fiscal year 2025 marked a foundational year for AIxC's strategic transformation.

LOS ANGELES, March 24, 2026 /PRNewswire/ -- AIxCrypto Holdings, Inc. (NASDAQ: AIXC, or the "Company"), today reported financial results for the fiscal year ended December 31, 2025 — its inaugural annual earnings release following its transformation from a clinical-stage biopharmaceutical company into an AI and blockchain-enabled digital infrastructure company spanning Real World Asset (RWA) tokenization, AI agents and Embodied AI (EAI) blockchain ecosystems, connecting Web2 and Web3. Fiscal year 2025 was principally a period of strategic repositioning, capital formation, and platform development.

LOS ANGELES, March 24, 2026 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ: AIXC) ("AIxC" or the "Company"), a technology company focused on infrastructure for the emerging Embodied AI (EAI) ecosystem, today shared a weekly business update from Co-CEO Jerry Wang highlighting recent industry engagement, the Company's continued long-term infrastructure focus, and broader industry developments relevant to the evolving AI Agent economy. Strategic Industry Engagement This week, Jerry Wang attended the annual meeting of Pinnacle Real Estate Group in California.

LOS ANGELES, March 22, 2026 /PRNewswire/ -- AIxCrypto Holdings Inc. (NASDAQ: AIXC) ("AIxCrypto" or the "Company") today acknowledged the public announcement made by its majority controlling stockholder, Faraday Future Intelligent Electric Inc., regarding the conclusion of a previously disclosed U.S. Securities and Exchange Commission (SEC) investigation, which FFAI announced has been resolved with no enforcement action recommended. The Company views this development as an important step toward reducing prior uncertainty associated with the matter.

LOS ANGELES, March 20, 2026 /PRNewswire/ -- AIxCrypto Holdings, Inc. ("AIxC" or the "Company"), a U.S.-Nasdaq listed company dedicated to building an ecosystem that integrates AI and blockchain while bridging Web2 and Web3, today announced that the Company is scheduled to report its fourth quarter financial results for 2025 after market close on Tuesday, March 24, 2026, and will hold an earnings call at 4:30 PM Pacific Time (7:30 PM Eastern Time) that same day. AIxC invites stockholders to submit questions in advance of the upcoming earnings call.
FARADAY FUTURE INTELLIGENT ELECTRIC INC.
10 percent owner
0 SH @ $0.00
2025-11-17
FARADAY FUTURE INTELLIGENT ELECTRIC INC.
10 percent owner
978,425 SH @ $2.25
2025-11-12
Wang Jiawei
officer: Co-Chief Executive Officer
0 SH @ $0.00
2025-09-29
Wang Jiawei
officer: Co-Chief Executive Officer
196 SH @ $445.23
2025-11-12